Cardinal Health ( CAH) posted a 17% rise in fourth-quarter profits and said its CEO and CFO are ready to certify the company's fiscal year end results. Cardinal earned $296.3 million, or 64 cents a share, in the quarter, up from $253.3 million, or 55 cents a share, a year ago. Excluding special charges relating to goodwill amortization, the company earned 74 cents a share, a penny better than the Thomson Financial/First Call consensus of 73 cents. Operating revenue was up 15% to $11.8 billion from $10.3 billion last year, while the pharmaceutical distribution segment's revenue was up 17% to $9.6 billion. The pharmaceutical technologies division saw revenue increase 13% to $359 million, and the medical-surgical products division posted 5% revenue growth to $1.6 billion. The company didn't provide any specific future guidance, but said its chief executive officer and chief financial officer are both ready to submit certifications as to the "completeness and accuracy of the company's applicable reports" in order to meet the Securities and Exchange Commission's new guidelines. Shares of Cardinal closed at $52.03 Monday before the earnings release.